Supercharged immune cells aim to prevent leukemia relapse after transplant

NCT ID NCT06158828

First seen Feb 15, 2026 · Last updated Apr 23, 2026 · Updated 8 times

Summary

This study tests whether giving special 'memory-like' natural killer (NK) cells after a stem cell transplant can help control high-risk acute myeloid leukemia (AML) in children and adults. Participants receive donor stem cells and later an infusion of these boosted NK cells. The goal is to see if this approach is safe and can reduce the chance of the cancer coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.